Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Oncothyreon Company Profile (NASDAQ:ONTY)

Consensus Ratings for Oncothyreon (NASDAQ:ONTY) (?)
Ratings Breakdown: 1 Hold Rating(s), 2 Buy Rating(s)
Consensus Rating:Buy (Score: 2.67)
Consensus Price Target: $3.83 (124.17% upside)

Analysts' Ratings History for Oncothyreon (NASDAQ:ONTY)
Show:
DateFirmActionRatingPrice TargetDetailsShare
9/10/2014ZacksUpgradeNeutral -> Outperform$2.50ViewTweet This Rating  Share This Rating on StockTwits
8/19/2014WedbushLower Price Target$6.00 -> $3.00ViewTweet This Rating  Share This Rating on StockTwits
3/14/2014Cantor FitzgeraldDowngradeBuy -> HoldViewTweet This Rating  Share This Rating on StockTwits
3/13/2014Stifel NicolausBoost Price TargetBuy$3.00 -> $6.00ViewTweet This Rating  Share This Rating on StockTwits
6/20/2013WedbushLower Price TargetOutperform$5.00 -> $3.00ViewTweet This Rating  Share This Rating on StockTwits
5/17/2013WedbushUpgradeNeutral -> Outperform$2.00 -> $5.00ViewTweet This Rating  Share This Rating on StockTwits
3/15/2013Cantor FitzgeraldReiterated RatingBuy$4.00 -> $4.00ViewTweet This Rating  Share This Rating on StockTwits
1/17/2013Piper JaffrayInitiated CoverageUnderweight$1.00ViewTweet This Rating  Share This Rating on StockTwits
12/19/2012WedbushDowngradeOutperform -> Neutral$31.00 -> $2.00ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 10/20/2012 forward)
Discuss Oncothyreon